{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"LTE60","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"Study began with 100mg BID mix \\& drink (MD) formulation. AstraZeneca (AZ) switched to hydrogen-sulfate capsule (HC). AZ deemed 100mg BID MD equivalent to 50mg BID HC. As of 12/31/2010, patients got 50mg BID HC; four patients were on treatment then."},"pointOfContact":{"email":"kurasa@nrgoncology.org","organization":"NRG Oncology Statistics and Data Management Center - Buffalo","phone":"716-845-7733","title":"Angela M. Kuras, Associate Director of Data Management"}}